[Heparins, antivitamins K. Principles and rules of use. Posology of non-fractionated heparins].
Delsart
D
D
Unité de pharmacologie clinique, service de médecine interne et thérapeutique, CHU, hôpital de Bellevue, 42055 Saint-Etienne.
Chambefort
V
V
Decousus
H
H
D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D001777:Blood Coagulation / Q000187:drug effects; D004347:Drug Interactions; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D006493:Heparin / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D011183:Postoperative Complications / Q000517:prevention & control; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy; D013923:Thromboembolism / Q000517:prevention & control; D013997:Time Factors; D020246:Venous Thrombosis / Q000188:drug therapy; D014812:Vitamin K / Q000037:antagonists & inhibitors*
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight; D014812:Vitamin K; D006493:Heparin
Héparines, antivitamines K. Principes et règles d'utilisation. Posologie des héparines non fractionnées.